BRPI0619759A2 - dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas - Google Patents

dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas Download PDF

Info

Publication number
BRPI0619759A2
BRPI0619759A2 BRPI0619759-0A BRPI0619759A BRPI0619759A2 BR PI0619759 A2 BRPI0619759 A2 BR PI0619759A2 BR PI0619759 A BRPI0619759 A BR PI0619759A BR PI0619759 A2 BRPI0619759 A2 BR PI0619759A2
Authority
BR
Brazil
Prior art keywords
formula
substituted
unsubstituted
compound according
mmol
Prior art date
Application number
BRPI0619759-0A
Other languages
English (en)
Portuguese (pt)
Inventor
H. Posner Gary
Paik Ikhyeon
Borstnik Kristina
Chang Wonsuk
Sinishtaj Sandra
Anthony Maio William
Gaetano D'angelo John
Elaine Woodard Lauren
Soloman Kalinda Alvin
R. Usera Aimee
Catherine Hess Lindsey
Scott Rosenthal Andrew
Oh Seongho
C. Baege Astrid
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of BRPI0619759A2 publication Critical patent/BRPI0619759A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0619759-0A 2005-12-08 2006-11-17 dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas BRPI0619759A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US74854805P 2005-12-08 2005-12-08
US60/748,548 2005-12-08
US76512506P 2006-02-03 2006-02-03
US60/765,125 2006-02-03
US79481106P 2006-04-25 2006-04-25
US60/794,811 2006-04-25
PCT/US2006/044845 WO2007067333A2 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Publications (1)

Publication Number Publication Date
BRPI0619759A2 true BRPI0619759A2 (pt) 2011-10-18

Family

ID=38123365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619759-0A BRPI0619759A2 (pt) 2005-12-08 2006-11-17 dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas

Country Status (10)

Country Link
US (1) US20090291923A1 (https=)
EP (1) EP1962596A4 (https=)
JP (1) JP2009518397A (https=)
KR (1) KR20080081310A (https=)
AU (1) AU2006323040A1 (https=)
BR (1) BRPI0619759A2 (https=)
CA (1) CA2632200A1 (https=)
IL (1) IL191597A0 (https=)
MX (1) MX2008007358A (https=)
WO (1) WO2007067333A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
US8592611B2 (en) 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010032165A2 (en) * 2008-09-19 2010-03-25 North-West University Prodrugs of artemisinin
US8884032B2 (en) 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
WO2011071947A2 (en) 2009-12-07 2011-06-16 Johns Hopkins University Bis-acylated hydroxylamine derivatives
US20110144067A1 (en) * 2009-12-07 2011-06-16 Toscano John P N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
US9493480B2 (en) 2011-04-15 2016-11-15 The Johns Hopkins University Monomeric trioxane amide sulfur compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121749A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev 2,3-dioxabicycloÚ3.3.1¾nonane derivatives and antimalarial pharmaceutical compositions comprising them
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
AU2003233509A1 (en) * 2002-05-07 2003-11-11 University Of Mississipi Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
WO2004028476A2 (en) * 2002-09-27 2004-04-08 Johns Hopkins University Artemisinin-derived trioxane dimers

Also Published As

Publication number Publication date
IL191597A0 (en) 2009-02-11
WO2007067333A2 (en) 2007-06-14
WO2007067333A3 (en) 2008-01-31
KR20080081310A (ko) 2008-09-09
AU2006323040A1 (en) 2007-06-14
EP1962596A2 (en) 2008-09-03
JP2009518397A (ja) 2009-05-07
US20090291923A1 (en) 2009-11-26
EP1962596A4 (en) 2010-09-22
MX2008007358A (es) 2008-11-10
CA2632200A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
JP7850663B2 (ja) スピロ環含有キナゾリン化合物
US11459327B1 (en) Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof
AU2018203354B2 (en) Hepatitis B antiviral agents
EP4092026A1 (en) Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereof
ES2834065T3 (es) Inhibidores de arginasa y sus aplicaciones terapéuticas
TW202341983A (zh) 用於降解突變kras蛋白之化合物及其應用
CA3146679A1 (en) Adenosine derivative and pharmaceutical composition comprising the same
UA121271C2 (uk) Заміщені 3-азабіцикло[3.1.0]гексани як інгібітори кетогексокінази
EA019749B1 (ru) Противовирусные соединения
AU2018291688B2 (en) Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections
US20250195475A1 (en) Cdk2 inhibitor and preparation method and use thereof
EP4238965A1 (en) 14-chloro-beta-elemene nitric oxide donor type derivative, preparation and application thereof
IL305009A (en) A prodrug compound, a method for its preparation and its use
CN114591201B (zh) 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用
TW201625313A (zh) 新穎麩胺酸衍生物及其用途
CA3082499A1 (en) Quinazolinone compound and application thereof
JP2021532107A (ja) ジカチオン化合物及びその製造方法と使用
BRPI0619759A2 (pt) dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas
JP2018536619A (ja) トリプトリドのc14ヒドロキシルエステル化アミノ酸誘導体、ならびにその製造方法および使用
CA3092544A1 (en) 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
EP2358198A1 (en) Hydroxyethylamino sulfonamide derivatives
CA3049428A1 (en) Small molecule inhibitors of neutral sphingomyelinase 2 (nsmase2) for the treatment of neurodegenerative diseases
CN101325874A (zh) 具有高抗癌活性和长效抗疟活性的三噁烷二聚物
EP3699184A1 (en) Triptolide derivative and preparation method therefor and use thereof
UA80409C2 (en) Hexacyclic compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]